The regulatory approvals of immune checkpoint inhibitors in China and the United States: A crossânational comparison study
Sign Up to like & getrecommendations! Published in 2023 at "International Journal of Cancer"
DOI: 10.1002/ijc.34427
Abstract: Immune checkpoint inhibitors (ICIs) are currently one of the most popular treatment methods for cancers. Several ICIs have been approved in China and the United States. We created a database of approved ICIs by extracting… read more here.
Keywords: regulatory approvals; immune checkpoint; checkpoint inhibitors; approvals immune ... See more keywords